Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating ELU42 topical spray for diabetic foot ulcers (Wagner Grade 1-2); recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELU42 topical spray (ELU42)

Snippet

Sponsor: Eluciderm Inc | Conditions: Diabetic Foot Ulcer, Wagner Grade 1 - 2 | Phase 1, Phase 2 | Status: RECRUITING